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Abstract
Objective Dairy food intake has been associated with
prostate cancer in previous work, but the mechanism by
which this occurs is unknown. Dairy calcium may suppress
circulating levels of potentially cancer-protective 1,25-hy
droxyvitamin D (1,25(OH)2D). We examined the associa
tions of dairy, milk, calcium, and vitamin D intake with
plasma 1,25(OH)2D levels among 296 men (194 black, 102
non-black) enrolled in a high risk program for prostate
cancer from 10/96 to 10/07.
Methods All participants completed diet and health his
tory questionnaires and provided plasma samples, which
were assessed for levels of 25-hydroxyvitamin D and
1,25(OH)2D. We used multivariate linear regression to
examine associations with 1,25(OH)2D.
Results After adjustment for age, race, energy intake,
BMI, and alcohol intake, we observed no associations for
any of our variables of interest with 1,25(OH)2D, or any

meaningful differences in estimates by race or vitamin D
status.
Conclusion Our ﬁndings, in a sample including a large
proportion of black participants, do not conﬁrm previous
ﬁndings showing an inverse association between calcium
intake and 1,25(OH)2D levels. As such, they suggest that
future work should explore other mechanisms by which
dairy foods and calcium might increase prostate cancer risk.
Keywords Dairy � Milk � Prostate neoplasms �
Vitamin D

Introduction
Although epidemiologic studies have fairly consistently
found an increase in prostate cancer risk with intake of dairy
foods [1], mechanisms by which dairy foods increase risk of
prostate cancer are unknown. The hypothesis that 1,25-di
hydroxyvitamin D (1,25(OH)2D) might protect against
prostate cancer [2] suggests one possible mechanism: con
sumed at sufﬁciently high levels, calcium in dairy suppresses
production and circulating levels of 1,25(OH)2D, thereby
increasing risk for prostate cancer [3]. Vitamin D, which is
derived primarily from the sunlight-catalyzed synthesis of 7
dehydrocholesterol in the skin, is converted through
hydroxylation ﬁrst to 25-hydroxyvitamin D (25(OH)D),
considered the better indicator for vitamin D status [4], then
again by the enzyme 25-hydroxyvitamin D-1alpha-hydrox
ylase (1alpha-OHase) to its biologically active form,
1,25(OH)2D [4]. The effect of dairy intake on 1,25(OH)2D
levels may differ by vitamin D status. Whereas a high level of
dairy calcium may increase risk among those with adequate
vitamin D status, in vitamin D deﬁcient men dairy foods may
increase levels of 25(OH)D, the precursor substrate for
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conversion to 1,25(OH)2D in the prostate [4], consequently,
increasing availability of 1,25(OH)2D (Fig. 1).
Conﬁrming associations within these pathways would
have important implications for dairy food and calcium
intake in prostate cancer prevention. These implications are
particularly relevant to men at high risk for prostate cancer,
for whom preventive measures are limited but are most
needed. The objectives of this analysis were to evaluate the
hypothesis that dairy food and calcium intake reduce cir
culating 1,25(OH)2D levels in a sample of men at high risk
for prostate cancer, including a large proportion of black
participants. We also hypothesized that the association of
dairy food intake with 1,25(OH)2D levels would differ by
vitamin D status.

Materials and methods
Study sample
Participants for the proposed study were men enrolled in
the Fox Chase Cancer Center (FCCC) Prostate Cancer Risk
Assessment Program (PRAP). PRAP was established by
FCCC investigators in 1996 to offer education and pre
ventive interventions to men at potentially high risk for
prostate cancer and to serve as a research base for studying
gene–environment interactions in prostate cancer [5].
PRAP participants are healthy men at high genetic risk for
prostate cancer. Men are eligible for the program if they are
between 35 and 69 years of age [1], and have no history of
prostate cancer [2]. In addition, non-black men are required
to have at least one-ﬁrst-degree relative or two same-side
second-degree relatives with prostate cancer; no family
history of prostate cancer is required for African American
men because of their already elevated risk. Recruitment
strategies include referrals from prostate cancer patients at
FCCC, radio and newspaper advertisements, and physician
and self-referrals.
Of 702 men enrolled in PRAP between October, 1996
and October, 2007, we excluded those who were recruited
through satellite locations and whose plasma samples thus
could not be processed immediately after collection

(n = 152); who did not provide a blood sample after July,
2000, when standard procedures were established for pro
cessing and storing plasma samples in the FCCC Biosample Repository (n = 116); who did not return a dietary
questionnaire (n = 108); who reported an infeasible energy
intake (\500 or [4,400 kcal/day) (n = 18); or who had a
previous diagnosis of cancer (n = 12), leaving 296 men
available for these analyses.
The project was approved by the Institutional Review
Board at the Fox Chase Cancer Center.
Data collection
Upon enrollment into PRAP, men completed a health
history questionnaire and the Harvard Diet Assessment
Form (DAF) [6]. At initial and follow-up appointments,
participants also contributed 51 mL of non-fasting blood
samples for storage in the FCCC Biosample Repository.
The health history questionnaire elicited information on
sociodemographic characteristics, occupation, family his
tory of prostate cancer, smoking status, physical activity,
and self-reported height and weight. Occupational sun
exposure was assessed based on each participant’s current
occupation, which was classiﬁed into one of three cate
gories according to presumed sunlight exposure (indoor
work, combined indoor and outdoor work, outdoor work),
using an index that was related to mortality from nonmelanoma skin cancer in previous studies [7–9]. The DAF
elicited information on frequency of intake of 126 food
items, and on length of use and dosage of dietary supple
ments, including calcium. Intake of speciﬁc nutrients such
as energy, total fat, and calcium was estimated by multi
plying reported frequency of intake of each food by the
nutrient content for the speciﬁed portion size.
Assessment of plasma 25(OH)D and 1,25(OH)2D levels
Levels of plasma 25(OH)D and 1,25(OH)2D were deter
mined by Heartland Assays, Inc. (Ames, IA). Levels of
25(OH)D were determined with a direct, competitive
chemiluminescence immunoassay (CLIA) using the
DiaSorin LIAISON platform. Levels of 1,25(OH)2D were

determined using a competitive RIA procedure following
extraction and subsequent puriﬁcation of vitamin D
metabolites from the plasma samples using C18OH
cartridges.

not meaningfully different, we present results for all men
or in subsets deﬁned only based on 25(OH)D levels.

Results
Statistical analyses
We used linear regression models adjusting for age and
race (black or non-black) to examine associations of soci
odemographic, lifestyle, and dietary factors with
1,25(OH)2D levels. Intake of dairy was calculated as the
total frequency of intake of nine items in the DAF: skim or
low fat milk, whole milk, cream, sour cream, ice cream,
yogurt, cottage or ricotta cheese; cream cheese, and other
cheese. Nutrient values, estimated from dietary and sup
plemental sources, were log-transformed as necessary and
energy-adjusted using the residual method [10]. Dietary
variables were modeled both as continuous variables and as
categorical variables with the lowest category as the ref
erent group. Categorical covariates were coded using
dummy variables to allow for non-linear associations
across categories.
Variables were included as potential confounders in
multivariate models if they were signiﬁcantly associated
with 1,25(OH)2D levels in models including all men. Final
multivariate models included 288 men with complete
covariate data and adjusted for age (years), race (black,
non-black), energy intake (kcal), BMI (kg/m2), and alcohol
intake (0,[0 to\6.5,[6.5 to\26, C26 g/day). Models for
dietary variables also adjusted for energy intake (kcal), and
models for calcium and vitamin D intake were mutually
adjusted for the other variable. Additional analyses with
25(OH)D as the outcome also adjusted for season of blood
draw because of its strong association with 25(OH)D lev
els. Other variables evaluated as confounders but not
included in ﬁnal models were level of education, family
history of prostate cancer, physical activity, total fat intake,
and occupational sun exposure.
To evaluate the possibility that associations differ by
vitamin D status, we compared estimates derived from
models stratiﬁed on 25(OH)D level. We deﬁned low
25(OH)D levels using a cut point of B15 ng/mL
(37.5 nmol/L), which deﬁnes the lower limit of the normal
range of 25(OH)D levels [11] and has been used as a cri
terion to deﬁne low vitamin D status in other studies [12,
13]. We estimated p-values for interaction from models
including all men, with dairy or calcium intake 9 vitamin
D status (25(OH)D level B 15 or [15 ng/mL) interaction
terms. Dairy and calcium variables were analyzed as both
continuous and categorical variables. We conducted similar
analyses to examine potential effect modiﬁcation by race
(black, non-black). Because results stratiﬁed on race were

Distributions of relevant variables and their associations
with 1,25(OH)2D level are shown in Table 1. The majority
of our sample (66%) were black, and about half of the
sample (47%) were classiﬁed as having low 25(OH)D
levels. Black participants were more likely to have low
vitamin D levels than were non-black participants (61% vs.
20%). Further, of 139 men with 25(OH)D level B 15 ng/mL,
119 (86%) were black, vs. 75 (48%) of 157 men with
25(OH)D level [ 15 ng/mL. In age- and race-adjusted lin
ear regression analyses, only 25(OH)D level was a signiﬁ
cant predictor of 1,25(OH)2D level, although associations
for BMI, vitamin D intake, and alcohol intake were
marginally signiﬁcant (Table 1). A surprisingly inverse
association of outdoor occupation with 1,25(OH)2D level
was non-signiﬁcant and based on only 10 men with occu
pations categorized as outdoor.
In unadjusted correlational analyses among the major
factors of interest shown in Fig. 1, dairy intake was
strongly correlated with calcium intake (Table 2); it was
also weakly correlated with vitamin D intake, but this was
signiﬁcant only when all men were included (Table 2).
Vitamin D intake was correlated with 25(OH)D level, but
only among men with low vitamin D status. Similarly,
25(OH)D and 1,25(OH)2D levels were correlated only
among men with low vitamin D status. 1,25(OH)2D was
not correlated with intake of dairy foods, calcium, or
vitamin D in these analyses.
In multivariate linear regression analyses adjusting for
BMI and alcohol intake as well as for age and race, we
observed no associations of total dairy food, total milk,
calcium, or vitamin D intake with 1,25(OH)2D levels in
models including all men, nor we did we see any evidence
of effect modiﬁcation by vitamin D status (Table 3). We
also saw no associations when we examined whole milk
and low fat milk separately (data not shown). When we
created categories to distinguish men with very high cal
cium intake, we still found no evidence that calcium
[1,500 mg/day was associated with lower 1,25(OH)2D
levels, although the estimate for the highest category was
based on only 16 men (data not shown).
In exploring our hypothesized associations among
dairy food intake, vitamin D intake, and levels of
25(OH)D and 1,25(OH)2D, we found that dietary vitamin
D was signiﬁcantly (beta = 0.004, p = 0.0001) associated
with 25(OH)D levels after adjustment for age, race, BMI,
intake of energy, alcohol, and calcium, and season of

Table 1 Distribution of variables among 296 participants in the Prostate Cancer Risk Assessment Program, and age- and race-adjusted
associations with 1,25(OH)2D
Betaa (p-value)

Variable
Mean (±SD) age (years)

49.9 (8.6)

\0.1 (0.52)

African American (%)

66

0.9 (0.64)

High school graduate

19

Ref

Some college

36

3.8 (0.14)

College graduate

27

2.5 (0.37)

Level of education (%)

18

1.8 (0.54)

Mean (±SD) BMI (kg/m2)b

Graduate degree

28.9 (5.1)

-0.3 (0.08)

Physical activity (h/week)

2.4 (2.1)

-0.3 (0.61)

Mean (SD)

10.5 (8.8)

0.1 (0.50)

Median (1st, 3rd quartiles)

8.4 (3.9, 14.2)

Dairy food intake (times/week)

Total milk intake (times/week)
Mean (SD)

3.2 (4.5)

Median (1st, 3rd quartiles)

1.0 (0.5, 3.5)

0.2 (0.32)

Whole milk intake (times/week)
Mean (SD)

0.6 (1.5)

Median (1st, 3rd quartiles)

0 (0, 0.5)

0.3 (0.64)

Skim/low fat milk intake (times/week)
Mean (SD)

2.6 (4.6)

Median (1st, 3rd quartiles)

0.5 (0, 3.0)

0.2 (0.4)

Mean (SD) energy intake (kcal/day)

1,982 (742)

-1.3 (0.28)

Mean (SD) calcium intake (mg/day)

718 (414)

1.1 (0.27)

Mean (SD) vitamin D intake (IU/day)

374 (312)

0.6 (0.06)

0 g/day

34

Ref

[0 to \6.5 g/day

27

3.5 (0.14)

Alcohol intake (%)

[6.5 to \26 g/day

29

4.1 (0.09)

C26 g/day

10

6.6 (0.05)

p-For-trendc

0.06

Occupational sun exposure (%)
Indoor

68

Ref

Mixed

26

0.9 (0.78)

Outdoor

6

-0.9 (0.87)

January–March

28

Ref

April–June

22

1.9 (0.47)

July–September
October–December

25
25

0.2 (0.94)
0.8 (0.76)

Mean (±SD) 25(OH)D (ng/mL)

15.9 (6.8)

0.5 (0.0005)

25(OH)D B 15 ng/mL (%)

47

-4.6 (0.02)

Mean (±SD) 1,25(OH)2D (pg/mL)

37.2 (15.7)

–

Season of blood draw (%)

a

Beta represents mean change in 1,25(OH)2D (pg/mL) for each 1,000 kcal increment in energy intake, 350 mg increment in calcium intake, and
100 IU increment in vitamin D intake. For all other continuous variables, beta represents mean change in outcome variable for each one-unit
increment in predictor variable. For categorical variables, betas represent mean difference in outcome relative to referent category
b

Due to missing data, n = 288 for BMI; n = 192 for physical activity; and n = 164 for occupational sun exposure

c

Trend p-value calculated by including alcohol as an ordinal categorical variable in the model

Table 2 Spearman correlations among dairy food (servings/week), calcium (mg/day), and vitamin D (IU/day) intake and levels of 25(OH)D (ng/
mL) and 1,25(OH)2D (pg/mL) among all 296 participants in the Prostate Cancer Risk Assessment Program, and stratiﬁed on vitamin D status
25(OH)D

1,25(OH)2D

0.15

0.21

0.01

(p 5 0.008)

(p 5 0.0003)

(p = 0.87)

0.29

0.05

Dairy food

Calcium

Vitamin D

1.0

0.53a
(p < 0.0001)
1.0

0.36

All men (n = 296)
Dairy food
Calcium
Vitamin D

(p < 0.0001)

(p < 0.0001)

(p = 0.39)

1.0

0.24

0.10

25(OH)D

(p < 0.0001)

(p = 0.10)

1.0

0.17
(p = 0.003)

1,25(OH)2D

1.0

25(OH)D [ 15 ng/mL (n = 157)
Dairy food

1.0

Calcium

0.56

0.14

0.003

(p < 0.0001)

(p = 0.09)

(p = 0.97)

(p = 0.98)

1.0

0.31

0.11

0.05

Vitamin D

-0.002

(p < 0.0001)

(p = 0.19)

(p = 0.52)

1.0

0.07

0.12

(p = 0.39)

(p = 0.13)

1.0

0.11

25(OH)D

(p = 0.17)
1,25(OH)2D

1.0

25(OH)D B 15 ng/mL (n = 139)
Dairy food

1.0

Calcium

0.44
(p < 0.0001)

0.11
(p = 0.21)

0.09
(p = 0.27)

-0.02
(p = 0.86)

1.0

0.37

0.24

-0.001

(p < 0.0001)

(p 5 0.004)

(p = 0.99)

1.0

0.32

0.01

(p 5 0.0002)

(p = 0.89)

1.0

0.25

Vitamin D
25(OH)D

(p 5 0.004)
1,25(OH)2D

1.0

Calcium and vitamin D intake were adjusted for energy intake using the residual method
a

Boldface indicates p \ 0.05

blood draw, regardless of vitamin D status (results not
shown). Levels of 25(OH)D, in turn, were signiﬁcantly
associated with 1,25(OH)2D levels, but only among men
with 25(OH)D levels B 15 ng/mL [beta = 0.98 (p =
0.01) for men with 25(OH)D B 15 ng/mL vs. beta = 0.37
(p = 0.28) for men with 25(OH)D [ 15 ng/mL]. Dairy
intake, however, was only weakly correlated with estimated
intake of vitamin D (Table 2), and neither dairy nor vitamin
D intake was associated with 1,25(OH)2D level (Table 3).

Discussion
We found that dairy food and calcium intake were not
associated with 1,25(OH)2D levels in our sample of men at

high risk for prostate cancer. Results did not differ by
vitamin D status or race, although an association of
25(OH)D with 1,25(OH)2D levels was limited to men with
25(OH)D levels B 15 ng/mL.
A potentially suppressive effect of calcium on produc
tion and circulating levels of 1,25(OH)2D is a primary
mechanism that has been suggested to explain the fairly
consistent association of dairy and calcium intake with
elevated prostate cancer risk. Prostate cells express
1a-hydroxylase, the enzyme that converts 25(OH)D to
1,25(OH)2D, but prostate cancer cells show a marked
decrease in 1a-hydroxylase activity [14], thus, possibly
increasing prostatic cell dependence on circulating 1,25
(OH)2D [15]. In experimental studies, 1,25(OH)2D reduces
cell proliferation, induces cell differentiation and

Table 3 Multivariate-adjusted mean 1,25(OH)2D levels by categories of dairy food, milk, calcium, and vitamin D intake in all men and stratiﬁed
on vitamin D status
Median

All men
n = 288

25(OH)D [ 15 ng/mL
n = 154

25(OH)D B 15 ng/mL
n = 134

n

Mean 1,25(OH)2D
(pg/mL)

n

Mean 1,25(OH)2D
(pg/mL)

n

Mean 1,25(OH)2D
(pg/mL)

3

74

36.7

29

41.4

45

33.7

Quartile 2

7

70

36.8

35

38.4

35

35.0

Quartile 3

10

70

37.1

37

34.8

33

40.5

Quartile 4

20

74

39.0

53

41.7

21

33.9

Dairy (times/week)
Quartile 1

p-Valuea

0.45

0.40

0.95

Total milk (times/week)
Quartile 1

0

69

35.8

36

36.9

33

33.8

Quartile 2

0.5

81

36.8

36

41.6

45

32.7

Quartile 3

3

67

39.6

29

39.5

38

38.9

Quartile 4

7

71

38.3

53

38.4

18

37.3

p-Value
Calcium (mg/day)
Quartile 1

0.27

0.49

0.53

427

69

37.0

29

38.4

40

34.9

Quartile 2

571

73

36.2

32

37.4

41

34.9

Quartile 3

725

72

38.1

41

39.4

31

36.6

Quartile 4

1,033

74

38.5

52

40.8

22

35.5

p-Value

0.40

0.41

0.69

Vitamin D (IU/day)
Quartile 1

116

71

36.4

29

33.4

42

38.6

Quartile 2

190

72

34.6

39

38.0

33

30.4

Quartile 3

397

72

40.3

37

43.3

35

37.0

Quartile 4

675

73

38.8

49

40.7

24

34.9

p-Value

0.15

0.14

0.96

Model adjusted for age, race, total energy intake, BMI, and alcohol intake. Models for calcium and vitamin D intake also adjusted for the others
as a continuous variable
a

p-Value for continuous variable

apoptosis, and disturbs cell survival signals in the signaling
pathway [16, 17], and these effects have been conﬁrmed in
prostate epithelial and cancer cells in animal models [3].
Despite tight regulation of circulating levels of
1,25(OH)2D, calcium intake may affect 1,25(OH)2D levels
by affecting circulating calcium levels. Low calcium levels
stimulate the release of parathyroid hormone, which in turn
stimulates the hydroxylation of 25(OH)D to 1,25(OH)2D.
High calcium levels may have the opposite effect [3].
We hypothesized that by increasing calcium intake and
availability, dairy food intake would be associated with
lower 1,25(OH)2D levels; particularly, among men with
adequate vitamin D status. Despite a strong correlation
between dairy food and calcium intake (r = 0.50,
p \ 0.0001), we did not observe an inverse association for
dairy food or calcium intake with 1,25(OH)2D level, even
in analyses limited to men with adequate vitamin D status,

or in additional analyses examining very high calcium
intake. While a recent analysis conducted in the Prostate,
Lung, Colorectal, and Ovarian Cancer Screening Trials
also showed no association between calcium intake and
1,25(OH)2D levels [18], several other studies have shown
an inverse correlation between the two [15, 19–26], even
within the range of usual calcium intake [20–22]. Never
theless, levels of 1,25(OH)2D are known to be tightly
regulated [11], and most of the studies showed relatively
small changes in 1,25(OH)2D levels with large variations
in calcium intake. Together, these studies suggest that an
association between calcium and 1,25(OH)2D, if any, is too
modest to explain the association between calcium and
prostate cancer risk. Moreover, despite fairly consistent
ﬁndings of an association for dairy and calcium intake with
prostate cancer, even studies on prediagnostic serum vita
min D levels and prostate cancer are inconsistent [27–31].

Whether suppression of 1,25(OH)2D levels is the primary
mechanism by which dairy/calcium increase prostate can
cer risk, therefore, remains an open question. Examining
determinants of intracellular rather than circulating
1,25(OH)2D may yield more insight into prostate cancer
risk, although measurement of intracellular 1,25(OH)2D in
epidemiologic studies poses logistical challenges.
Among men with low vitamin D status we hypothesized
that by increasing vitamin D intake dairy food intake would
increase rather than decrease 1,25(OH)2D levels. The null
ﬁndings in this low vitamin D status sample—mean
25(OH)D in our sample was 15.9 ng/mL, compared with
31.5 ng/mL in the Third National Health and Nutrition
Examination Survey (20.9 ng/mL among black participants
only) [32]—argues against this hypothesis. Although vita
min D intake in our sample was signiﬁcantly associated
with higher 25(OH)D levels, which was in turn associated
with higher 1,25(OH)2D levels, dairy food intake was only
weakly correlated with vitamin D intake, suggesting that
other dietary sources of vitamin D are likely to be impor
tant. Also worth noting is that dietary vitamin D was not
associated with 1,25(OH)2D level, possibly due in part to
tight regulation of 1,25(OH)2D, as well as to measurement
error in estimating vitamin D intake [11]. Notably, previ
ous studies have also not demonstrated a protective effect
of dietary vitamin D for prostate cancer [22, 33–36].
We observed a marginally signiﬁcant association of
alcohol intake with 1,25(OH) 2D level. Alcohol abuse is
known to disrupt bone metabolism, but the limited evi
dence available suggests that it would decrease rather than
increase 1,25(OH)2D level [37]. With no a priori reason to
expect a positive association between alcohol intake and
1,25(OH) 2D, this ﬁnding warrants conﬁrmation in other
studies before further interpretation is possible.
Several limitations of this analysis merit discussion.
First, our sample included men at high genetic risk for
prostate cancer based on their race and/or family history. To
the extent that circulating levels of 1,25(OH)2D are genet
ically inﬂuenced, their heritable component may over
whelm the effects of non-genetic factors such as diet. While
it is unlikely that high risk men would be less responsive to
dietary factors inﬂuencing vitamin D levels, we did attempt
to account for genetic effects using information on men’s
family history of prostate cancer but saw no association of
family history with 1,25(OH)2D levels. Also, because black
participants were eligible for PRAP regardless of their
family history of prostate cancer, our ﬁndings have impli
cations for black men in general. Indeed, despite our rela
tively small sample size, our analysis is the largest
examination of these relationships among black men.
Measurement error in estimating dietary intake is
another potential limitation, although one study demon
strated good validity of the questionnaire in an ethnically

diverse sample [38]. That dietary questionnaires were not
always completed at the same time as the blood collection
may have led to some error as well, although the median
time between dietary questionnaire completion and blood
draw for the 296 men in our analysis was only 12 days.
In summary, in this sample of men at high risk for
prostate cancer, dairy, milk, and calcium intake were not
associated with reduced 1,25(OH)2D levels. Among men
with low vitamin D status, vitamin D intake contributed to
higher 25(OH)D levels, which were in turn associated with
levels of 1,25(OH)2D, but we were unable to conﬁrm a
direct association of dairy or vitamin D intake with
1,25(OH)2D levels in these men. Our ﬁndings, in a sample
including a large proportion of black participants, do not
conﬁrm previous ﬁndings showing an inverse association
between calcium intake and 1,25(OH)2D levels. As such,
they suggest that future work should explore other mech
anisms by which dairy foods and calcium might increase
prostate cancer risk.
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